ENDRA Life Sciences (NDRA) Revenue & Revenue Breakdown
ENDRA Life Sciences Revenue Highlights
ENDRA Life Sciences Revenue by Period
ENDRA Life Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $6.17K | -98.24% |
| 2017-12-31 | $351.62K | -31.80% |
| 2016-12-31 | $515.58K | -63.44% |
| 2015-12-31 | $1.41M | 152.09% |
| 2014-12-31 | $559.36K | - |
ENDRA Life Sciences generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
ENDRA Life Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $428.41K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | -100.00% |
| 2018-03-31 | $6.17K | -9.87% |
| 2017-12-31 | $6.85K | -97.61% |
| 2017-09-30 | $287.00K | 396.78% |
| 2017-06-30 | $57.77K | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $515.58K | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | -100.00% |
| 2015-12-31 | $255.00K | -21.80% |
| 2015-09-30 | $326.08K | - |
ENDRA Life Sciences generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
ENDRA Life Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LAB | Standard BioTools | $106.34M | $37.20M |
| STIM | Neuronetics | $71.35M | $16.45M |
| BDSX | Biodesix | $49.09M | $14.82M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| HTGM | HTG Molecular Diagnostics | $6.37M | $1.03M |
| INBS | Intelligent Bio Solutions | $1.26M | $823.80K |
| SERA | Sera Prognostics | $306.00K | - |
| SQL | SeqLL | $1.18K | - |
| NDRA | ENDRA Life Sciences | - | - |
NDRA Revenue FAQ
What is ENDRA Life Sciences’s yearly revenue?
ENDRA Life Sciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. NDRA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is ENDRA Life Sciences’s quarterly revenue?
ENDRA Life Sciences's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $428.41K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). NDRA's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is ENDRA Life Sciences’s revenue growth rate?
ENDRA Life Sciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.